There has been a recent surge in interest in the use of
more continuous processes in the pharma industry, as the
benefits have become more widely known. This is due to the
availability of more expertise in the area of flow chemistry
over the last decade, in combination with the need for
the industry to develop safer, faster and more sustainable
processes, with higher quality and less expensive products.
Sam Tadayon, Executive Director at STA Pharmaceutical,
specifically looks at the improvements flow chemistry can
bring to process development and manufacturing for APIs.